Ross introduces a new Ribbon Blender

Published: 27-Feb-2012
Manufacturing

The multipurpose unit is ideal for most laboratory and pilot-scale blending requirements

Ross introduces a new Ribbon Blender Model, the 42NSD-1S, a multi-purpose unit equipped with interchangeable double ribbon and paddle agitators. With a maximum working capacity of 1 ft3, the 42NSD-1S is ideal for most laboratory and pilot-scale blending requirements.

This vacuum-rated blender also comes with a Discharge Extruder Assembly installed along the bottom of the trough to enhance mixing, eliminate dead zones and enable 100% complete discharge. The unit shown is supplied with NEMA 4X controls with variable frequency drive (VFD) keypad for convenient soft start and speed control of both the main agitator and the screw auger of the discharge extruder.

Ross Ribbon Blenders are commonly used for blending dry powders, granules, pellets and other solid forms. The agitator’s inner and outer helical ribbons are pitched to move material axially, in opposing directions, and also radially. This combination promotes fast and thorough blending. Paddle agitators deliver gentler mixing which is more suited for shear-sensitive and friable applications.

Both systems also function as paste mixers, vacuum dryers and granulators/coaters (evenly coating a liquid or very fine solid component throughout the surfaces of larger particle ingredients).

All Ross blenders are direct-driven by an inverter-ready gearmotor, a low-maintenance design superior to antiquated belt- and chain-driven blenders, which suffer from losses in horsepower and efficiency through slippage.

Popular options include sight/charge ports, safety gratings, pneumatically-operated covers and discharge valves, sanitary construction, spray bar assembly, heating/cooling jacket, caster wheels for portability, explosion-proof operator stations and HMI/PLC systems.

See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Accelerating the development of bispecific antibodies

Read more
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market

Trending Articles

  1. Adragos Pharma acquires Sanofi's Maisons-Alfort sterile fill-finish facility to strengthen European injectables network Global CDMO Adragos Pharma has completed the acquisition of one of Europe's largest sterile injectables manufacturing sites from Sanofi in Maisons-Alfort, France, adding high-volume pre-filled syringe capabilities to its existing fill-finish operations in Switzerland and Livron
  2. Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development Lonza to provide cGMP manufacturing and technical support to advance bimiralisib into late-stage clinical development
  3. Marchesini Group at Interpack 2026 Sustainability, primary packaging, aseptic production, robotics and digital innovation at the heart of this edition
  4. L.B. Bohle hosts successful continuous manufacturing workshop in Brazil Focus on continuous wet granulation and drying for research, development and small-scale production
  5. Symbiosis completes full ICH climatic zone coverage with new stability chamber addition Sterile injectable CDMO Symbiosis Pharmaceutical Services has installed a 30°C stability chamber at its Stirling facility, completing its coverage of all four ICH-defined climatic zones and strengthening its commercial drug product supply capabilities for global markets

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Accelerating the development of bispecific antibodies

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market
Manufacturing

UK pharmaceutical manufacturers struggling to meet F-Gas compliance amid ageing cooling infrastructure

A new Aggreko report reveals that nearly all UK pharmaceutical manufacturers are facing barriers to upgrading cooling systems ahead of the accelerating F-Gas phase-down timeline
Manufacturing

Labtex - Fresh thinking and innovative solutions

Labtex states: "We are proud to provide unique solutions for laboratories and pilot plants across the UK"
Manufacturing

Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform

The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering
Manufacturing

L.B. Bohle hosts successful continuous manufacturing workshop in Brazil

Focus on continuous wet granulation and drying for research, development and small-scale production
Manufacturing

Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development

Lonza to provide cGMP manufacturing and technical support to advance bimiralisib into late-stage clinical development
Manufacturing

Symbiosis completes full ICH climatic zone coverage with new stability chamber addition

Sterile injectable CDMO Symbiosis Pharmaceutical Services has installed a 30°C stability chamber at its Stirling facility, completing its coverage of all four ICH-defined climatic zones and strengthening its commercial drug product supply capabilities for global markets
Subscribe now